🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Conjunctival Transpositional Surgery for Primary Pterygium

RecruitingNAAges 18 Years - anyAllZahedan University of Medical Sciences
NCT07343011 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older * Primary pterygium involving the cornea * Ability to provide informed consent Exclusion Criteria: * Recurrent pterygium * Previous ocular surface surgery * Active ocular infection or inflammation * Severe ocular surface disease
💊

What it tests

  • Conjunctival Transpositional Pterygium Surgery
📍

Where

1 site
Alzahra Eye Hospital, Zahedan University of Medical Sciences
Zahedan, Iran
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy